Provided by Goodwin
Our globally recognized Life Sciences practice is uniquely positioned to partner with innovators and investors operating in a fast-moving, tech-driven environment. With more than 230 dedicated lawyers across all major life sciences hubs in the US, Europe, and Asia, we work with life sciences companies throughout the corporate lifecycle – from startup and commercial-stage to maturity – as well as investors, banks, and others in the life sciences ecosystem.
We understand the unique challenges life science companies face in securing funding, licensing and safeguarding intellectual property, establishing partnerships, bringing new products to market, opening new revenue streams, and protecting existing product lines. We take a multidisciplinary approach to address clients’ challenges, drawing on our deep expertise across industries – such as technology, healthcare, real estate, and private equity – as well as the full spectrum of relevant practices.
Provided by Chambers
Goodwin is adept at handling a range of corporate matters including strategic partnerships, M&A and public and private financings. The firm is skilled at the handling of PTAB post-grant reviews, IP portfolio management, patent litigation and regulatory advice on issues such as new drug approvals and securities disclosure.
Provided by Goodwin
Goodwin advised Nimbus Therapeutics on its sale to Takeda of Nimbus Lakshmi, Inc and its tyrosine kinase 2 inhibitor program for $4 billion upfront and up to $2 billion in commercial-related milestone payments.
Provided by Chambers
"Goodwin has a knowledgeable team with great experience."
"The Goodwin team takes a very practical, measured and balanced approach."
"They provide a tier one level service."
"Goodwin has a knowledgeable team with great experience."
"The Goodwin team takes a very practical, measured and balanced approach."
"They provide a tier one level service."
Provided by Chambers
Kingsley Taft advises life sciences businesses at every stage of operation and in a wide range of processes, such as strategic alliances and collaborations, venture financings and company formation.
Mitchell Bloom advises emerging innovator companies, investment banks and venture capital firms worldwide on capital markets offerings, M&A and venture capital transactions.